Primary sources first
Pages prioritize primary literature, regulatory sources, clinical trial records, drug labels, and systematic reviews where available.
Independent evidence index / reviewed 27 August 2026
Evidence-Based Peptide Research Database
ExaminePeptides summarizes peptide research, safety signals, mechanisms, regulatory status, and primary sources for 117+ compounds, then connects that evidence to neutral tracking tools and independent app evaluations.
Evidence that leads somewhere useful
Keep a dated observation record, audit a peptide claim, organize primary sources, or evaluate a tracking app. The practical layer is separate from clinical claims and every commercial relationship is disclosed beside the link.
How evidence is reviewed
Evidence limits stated clearly
When human clinical evidence is limited, the page should say so instead of treating animal or in vitro findings as settled outcomes.
Human outcomes separated
Each page distinguishes human outcomes from animal, cell, and mechanistic findings.
ExaminePeptides FAQ
What is ExaminePeptides?
ExaminePeptides is an independent evidence index covering 117+ peptide compounds, mechanisms, safety signals, regulatory status, comparisons, primary sources, and practical research tools.
How does ExaminePeptides evaluate evidence?
Pages prioritize primary literature, trial registries, drug labels, and regulatory sources. They separate human outcomes from animal or mechanistic findings and state when evidence is indirect, unreplicated, or investigational.
How is ExaminePeptides funded?
The core database and current downloads are free. ExaminePeptides may later earn commissions from clearly disclosed software links or sell research organization tools; commercial relationships do not determine evidence grades.